{
    "2020-12-18": [
        [
            {
                "time": "",
                "original_text": "【权益变动】泰格医药(03347-HK)被摩根大通减持18.1168万股 减持股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "摩根大通",
                        "减持",
                        "权益变动"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业事项点评：医保谈判落下帷幕 核心品种结果好于预期",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医保谈判",
                        "核心品种",
                        "好于预期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【异动股】泰格医药(03347-HK)涨3.51%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "涨",
                        "异动股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "富时罗素调整成分股，京东健康、泰格医药等获纳入",
                "features": {
                    "keywords": [
                        "富时罗素",
                        "成分股",
                        "调整",
                        "京东健康",
                        "泰格医药",
                        "纳入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}